Kimberly-Clark(US:KMB)2026-01-27 11:37Financial Performance - Net sales for Q4 2025 were $4.1 billion, down 0.6%, with organic sales growth of 2.1% offset by a 2.5% decline from exiting the private label diaper business in the US [4]. - Adjusted operating profit for Q4 2025 was $629 million, up 13.1% year-over-year, driven by strong productivity gains and lower expenses [7]. - Diluted earnings per share (EPS) for Q4 2025 were $1.50, with adjusted EPS increasing 24.0% to $1.86, reflecting strong operating profit delivery [11]. - Full year 2025 net sales were $16.4 billion, a decrease of 2.1%, primarily due to a 2.9% negative impact from divestitures and a 0.9% impact from foreign currency translation [12]. - Full year 2025 adjusted operating profit was $2.7 billion, in line with the prior year, despite headwinds from divestitures [15]. - Net income attributable to Kimberly-Clark Corporation for Q4 2025 was $499 million, representing an increase of 11.6% from $447 million in Q4 2024 [42]. - For the full year 2025, net sales were $16,447 million, down 2.1% from $16,805 million in 2024 [44]. - The operating profit for the full year 2025 decreased by 12.9% to $2,351 million, compared to $2,700 million in 2024 [44]. - Net income for the twelve months ended December 31, 2025, was $2,049 million, a decrease of 20.5% from $2,578 million in 2024 [48]. - Total net sales for the twelve months ended December 31, 2025, were $16,447 million, down 2.1% from $16,805 million in 2024 [50]. - Operating profit for the twelve months ended December 31, 2025, was $2,351 million, a decline of 12.9% compared to $2,700 million in 2024 [50]. Cash Flow and Capital Expenditures - Cash provided by operations in 2025 was $2.8 billion, down from $3.2 billion the previous year, while capital spending increased to $1.1 billion [31]. - Cash provided by operations for the twelve months ended December 31, 2025, was $2,777 million, down from $3,234 million in 2024 [48]. - Capital spending for the twelve months ended December 31, 2025, increased to $1,138 million from $721 million in 2024 [48]. - Cash dividends declared increased by 3.3% to $1.26 per share in Q4 2025, compared to $1.22 in Q4 2024 [42]. - Cash dividends paid for the twelve months ended December 31, 2025, were $1,660 million, slightly up from $1,628 million in 2024 [48]. Future Outlook - The company expects 2026 organic sales growth to align with or exceed the average growth in its competitive categories, projected at approximately 2% [32]. - Adjusted operating profit for 2026 is expected to grow at a mid-to-high single-digit rate on a constant-currency basis [32]. - Adjusted EPS from continuing operations for 2026 is expected to grow double-digit on a constant-currency basis, driven by a 30% increase in income from equity companies [32]. Shareholder Actions - The company completed share repurchases of 1.1 million shares at a cost of $141 million in 2025 [31]. Mergers and Acquisitions - The company is pursuing mergers with Kenvue and a joint venture with Suzano, which are expected to impact future growth and cost savings [37]. - The Kenvue acquisition is ongoing, with associated costs impacting financial results [58]. - Kenvue Acquisition added $32 million to Operating Profit in Q4 2025, with no contribution in Q4 2024 [62]. Operational Initiatives - The 2024 Transformation Initiative aims to enhance operational agility and improve growth trajectory and profitability [58]. - The 2024 Transformation Initiative contributed $90 million to Operating Profit in Q4 2025, compared to $97 million in Q4 2024 [62]. Tax and Legal Matters - The Effective Tax Rate as reported for the year ended December 31, 2025, was 29.2%, while the adjusted rate was 22.8% [64]. - The company reported a legal expense of $39 million in Q4 2024, which did not recur in Q4 2025 [62]. Other Financial Metrics - Basic earnings per share for Q4 2025 were $1.50, an increase of 11.9% from $1.34 in Q4 2024 [42]. - Income from Discontinued Operations for Q4 2025 was $142 million, up from $103 million in Q4 2024, a 37.9% increase [65]. - Organic sales growth for the year ended December 31, 2025, was 1.7%, with North America showing a growth of 1.8% and IPC at 1.7% [59]. - Total assets as of December 31, 2025, were $17,098 million, an increase from $16,546 million in 2024 [46]. - Current liabilities increased to $7,125 million in 2025 from $7,004 million in 2024 [46].